brand tirzepatide Lilly, Novo Fight Weight Loss Drug Compounders Over Shortage Republican Administration Maintains Exclusivity Stance
Description
107(4): p
Lee S et al
New Medicare prices are almost 70% lower than ICER
Some research shows tirzepatide may lead to stronger appetite control for some adults
Some GLP-1 medications have demonstrated cardiovascular protective effects in specific populationsliraglutide, semaglutide injection, and dulaglutide have shown cardiovascular outcome benefits, with Wegovy (semaglutide) recently receiving an FDA indication for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity
LEARN MORE Root-cause wellness evaluations and personalized treatment plans by Celeste Cisneros, FNP-BC
